Spyre Therapeutics, Inc. ( AGLE) - Stock Earnings
Stock symbol AGLE is outdated, potentially delisted? Maybe it is available on other exchange?
AGLE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -22.3 million USD | 625000 USD |
| 2022Q3 | -18.2 million USD | 174000 USD |
| 2022Q4 | -18.8 million USD | 168000 USD |
AGLE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -80.9 million USD | 0 USD |
| 2021 | -65.8 million USD | 18.7 million USD |
| 2022 | -83.8 million USD | 2.3 million USD |
AGLE
Price: $12.01
52 week price:
Earnings Per Share: -1.84 USD
P/E Ratio: -4.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 59052
Ebitda: -7.9 millionMarket Capitalization: 48.6 million